These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 2880492)
41. [Interactions between antihypertensive drugs]. Takagi M; Matsuoka H Nihon Rinsho; 1992 May; 50 Suppl():23-27. PubMed ID: 1355126 [No Abstract] [Full Text] [Related]
42. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy]. Agabiti-Rosei E Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883 [TBL] [Abstract][Full Text] [Related]
43. Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension. Hayashi K; Ozawa Y; Fujiwara K; Wakino S; Kumagai H; Saruta T Am J Nephrol; 2003; 23(4):229-44. PubMed ID: 12840599 [TBL] [Abstract][Full Text] [Related]
44. Role of the renal microcirculation in antihypertensive therapy. Inman SR; Stowe NT; Vidt DG Cleve Clin J Med; 1994; 61(5):356-62. PubMed ID: 7955308 [TBL] [Abstract][Full Text] [Related]
45. Combination antihypertensive therapy in the treatment of diabetic nephropathy. Boner G; Cao Z; Cooper ME Diabetes Technol Ther; 2002; 4(3):313-21. PubMed ID: 12165170 [TBL] [Abstract][Full Text] [Related]
46. Systemic and regional haemodynamic effects of vasodilators in hypertension. Struyker-Boudier HA; Smits JF Neth J Med; 1984; 27(4):146-52. PubMed ID: 6330588 [No Abstract] [Full Text] [Related]
47. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats. Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768 [TBL] [Abstract][Full Text] [Related]
48. [Nephro-protection: role of arterial pressure in progression of renal pathology. Does a nephro-protective effect depend on the choice of antihypertensive drug?]. Shestakova MV Ter Arkh; 2001; 73(6):64-6. PubMed ID: 11521527 [No Abstract] [Full Text] [Related]
49. A rational approach to hypertension treatment in the older patient. Flack JM; Woolley A; Esunge P; Grimm RH Geriatrics; 1992 Nov; 47(11):24-8, 33-8. PubMed ID: 1358761 [No Abstract] [Full Text] [Related]
50. The effect of antihypertensive agents on new-onset diabetes mellitus: time to amend the guidelines? Aksnes TA; Kjeldsen SE; Mancia G Am J Cardiovasc Drugs; 2006; 6(3):139-47. PubMed ID: 16780387 [TBL] [Abstract][Full Text] [Related]
53. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations? Hilgers KF; Mann JF Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734 [No Abstract] [Full Text] [Related]
54. [Relationship between essential arterial hypertension and osteoporosis:impact of antihypertensive treatment on extracellular metabolism of calcium]. Honorato Pérez J; Escolar Jurado M; García Quetglas E Rev Clin Esp; 1999 Aug; 199(8):523-9. PubMed ID: 10522434 [No Abstract] [Full Text] [Related]
55. [Chronotherapeutic evaluation of the antihypertensive treatment]. Lemmer B Rev Esp Cardiol; 1999; 52 Suppl 3():45-52. PubMed ID: 10614149 [TBL] [Abstract][Full Text] [Related]
56. The effect of antihypertensive drugs on the fetus. Rosenthal T; Oparil S J Hum Hypertens; 2002 May; 16(5):293-8. PubMed ID: 12082488 [TBL] [Abstract][Full Text] [Related]
58. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors]. Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714 [TBL] [Abstract][Full Text] [Related]